Related Experiment Video

Updated: May 21, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation

Hu Xiaowen1, Sun Yi

  • 1Department of Pharmacy, Cancer Hospital, Fudan University, Shanghai 200032, China.

Molecular Biology Reports
|June 19, 2012
PubMed

Insights

Triptolide, a Chinese medicine, sensitizes prostate cancer cells to TRAIL therapy by increasing DR5 expression. This mechanism involves suppressing the Akt/Hdm2 pathway, offering a potential new treatment for prostate cancer progression.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Prostate cancer cells often resist Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) therapy.
  • TRAIL is a promising anti-cancer agent, but its efficacy is limited by resistance mechanisms.

Purpose of the Study:

  • To investigate if Triptolide can sensitize prostate cancer cells to TRAIL-mediated apoptosis.
  • To elucidate the molecular mechanisms underlying Triptolide's sensitizing effect.

Main Methods:

  • Treating prostate cancer cells with Triptolide and/or TRAIL.
  • Analyzing DR5 expression levels.
  • Investigating the Akt/Hdm2 signaling pathway and p53 accumulation.

Main Results:

  • Triptolide significantly sensitized prostate cancer cells to TRAIL-induced apoptosis.
  • Triptolide upregulated the expression of DR5.
  • Triptolide suppressed the Akt/Hdm2 signaling pathway, leading to p53 accumulation.

Conclusions:

  • Triptolide enhances TRAIL-mediated apoptosis in prostate cancer by up-regulating DR5 expression via the Akt/Hdm2/p53 pathway.
  • Triptolide shows potential as a therapeutic agent to overcome TRAIL resistance and prevent prostate cancer progression.

More Related Videos

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...